JENNIFER VAN FOSSEN: Open Payments
NPI 1659892537 · POWELL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 26 payments from 15 companies in 2025. Trend: 2023 $164 · 2024 $0 · 2025 $648
Food & beverage: $549Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $182 |
| Actelion Pharmaceuticals US, Inc. | 2 | $124 |
| Amgen Inc. | 4 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Abbott Laboratories | 2 | $38 |
| Novo Nordisk Inc | 2 | $31 |
| PFIZER INC. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 2 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: FARXIGA, OPSUMIT, EVENITY, CAPLYTA, FREESTYLE LIBRE 3, BREZTRI, ELIQUIS, SPRAVATO.
Industry payments across OH — which companies pay providers there.
